Global Bio-pharma Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Bio-pharma Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Bio-pharma by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Bio-pharma by Country/Region, 2017, 2022 & 2028

2.2 Bio-pharma Segment by Type

2.2.1 Monoclonal Antibodies

2.2.2 Recombinant Proteins

2.2.3 Granulocyte-Colony Stimulating Factor (G-CSF)

2.2.4 Interferons

2.2.5 Recombinant Human Insulin

2.2.6 Erythropoietin

2.2.7 Vaccines

2.2.8 Growth Hormones

2.2.9 Purified Proteins

2.2.10 Others

2.3 Bio-pharma Sales by Type

2.3.1 Global Bio-pharma Sales Market Share by Type (2017-2022)

2.3.2 Global Bio-pharma Revenue and Market Share by Type (2017-2022)

2.3.3 Global Bio-pharma Sale Price by Type (2017-2022)

2.4 Bio-pharma Segment by Application

2.4.1 Metabolic Disorders

2.4.2 Oncology

2.4.3 Neurological Disorders

2.4.4 Cardiovascular Diseases

2.4.5 Inflammatory and Infectious Diseases

2.4.6 Others

2.5 Bio-pharma Sales by Application

2.5.1 Global Bio-pharma Sale Market Share by Application (2017-2022)

2.5.2 Global Bio-pharma Revenue and Market Share by Application (2017-2022)

2.5.3 Global Bio-pharma Sale Price by Application (2017-2022)

3 Global Bio-pharma by Company

3.1 Global Bio-pharma Breakdown Data by Company

3.1.1 Global Bio-pharma Annual Sales by Company (2020-2022)

3.1.2 Global Bio-pharma Sales Market Share by Company (2020-2022)

3.2 Global Bio-pharma Annual Revenue by Company (2020-2022)

3.2.1 Global Bio-pharma Revenue by Company (2020-2022)

3.2.2 Global Bio-pharma Revenue Market Share by Company (2020-2022)

3.3 Global Bio-pharma Sale Price by Company

3.4 Key Manufacturers Bio-pharma Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Bio-pharma Product Location Distribution

3.4.2 Players Bio-pharma Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Bio-pharma by Geographic Region

4.1 World Historic Bio-pharma Market Size by Geographic Region (2017-2022)

4.1.1 Global Bio-pharma Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Bio-pharma Annual Revenue by Geographic Region

4.2 World Historic Bio-pharma Market Size by Country/Region (2017-2022)

4.2.1 Global Bio-pharma Annual Sales by Country/Region (2017-2022)

4.2.2 Global Bio-pharma Annual Revenue by Country/Region

4.3 Americas Bio-pharma Sales Growth

4.4 APAC Bio-pharma Sales Growth

4.5 Europe Bio-pharma Sales Growth

4.6 Middle East & Africa Bio-pharma Sales Growth

5 Americas

5.1 Americas Bio-pharma Sales by Country

5.1.1 Americas Bio-pharma Sales by Country (2017-2022)

5.1.2 Americas Bio-pharma Revenue by Country (2017-2022)

5.2 Americas Bio-pharma Sales by Type

5.3 Americas Bio-pharma Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Bio-pharma Sales by Region

6.1.1 APAC Bio-pharma Sales by Region (2017-2022)

6.1.2 APAC Bio-pharma Revenue by Region (2017-2022)

6.2 APAC Bio-pharma Sales by Type

6.3 APAC Bio-pharma Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Bio-pharma by Country

7.1.1 Europe Bio-pharma Sales by Country (2017-2022)

7.1.2 Europe Bio-pharma Revenue by Country (2017-2022)

7.2 Europe Bio-pharma Sales by Type

7.3 Europe Bio-pharma Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Bio-pharma by Country

8.1.1 Middle East & Africa Bio-pharma Sales by Country (2017-2022)

8.1.2 Middle East & Africa Bio-pharma Revenue by Country (2017-2022)

8.2 Middle East & Africa Bio-pharma Sales by Type

8.3 Middle East & Africa Bio-pharma Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Bio-pharma

10.3 Manufacturing Process Analysis of Bio-pharma

10.4 Industry Chain Structure of Bio-pharma

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Bio-pharma Distributors

11.3 Bio-pharma Customer

12 World Forecast Review for Bio-pharma by Geographic Region

12.1 Global Bio-pharma Market Size Forecast by Region

12.1.1 Global Bio-pharma Forecast by Region (2023-2028)

12.1.2 Global Bio-pharma Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Bio-pharma Forecast by Type

12.7 Global Bio-pharma Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Bio-pharma Product Offered

13.1.3 Pfizer Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 F. Hoffmann-La Roche AG

13.2.1 F. Hoffmann-La Roche AG Company Information

13.2.2 F. Hoffmann-La Roche AG Bio-pharma Product Offered

13.2.3 F. Hoffmann-La Roche AG Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 F. Hoffmann-La Roche AG Main Business Overview

13.2.5 F. Hoffmann-La Roche AG Latest Developments

13.3 Johnson & Johnson Services

13.3.1 Johnson & Johnson Services Company Information

13.3.2 Johnson & Johnson Services Bio-pharma Product Offered

13.3.3 Johnson & Johnson Services Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Johnson & Johnson Services Main Business Overview

13.3.5 Johnson & Johnson Services Latest Developments

13.4 Sanofi, Amgen

13.4.1 Sanofi, Amgen Company Information

13.4.2 Sanofi, Amgen Bio-pharma Product Offered

13.4.3 Sanofi, Amgen Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sanofi, Amgen Main Business Overview

13.4.5 Sanofi, Amgen Latest Developments

13.5 AbbVie

13.5.1 AbbVie Company Information

13.5.2 AbbVie Bio-pharma Product Offered

13.5.3 AbbVie Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 AbbVie Main Business Overview

13.5.5 AbbVie Latest Developments

13.6 Merck & Co., Inc

13.6.1 Merck & Co., Inc Company Information

13.6.2 Merck & Co., Inc Bio-pharma Product Offered

13.6.3 Merck & Co., Inc Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Merck & Co., Inc Main Business Overview

13.6.5 Merck & Co., Inc Latest Developments

13.7 Biogen Idec

13.7.1 Biogen Idec Company Information

13.7.2 Biogen Idec Bio-pharma Product Offered

13.7.3 Biogen Idec Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Biogen Idec Main Business Overview

13.7.5 Biogen Idec Latest Developments

13.8 Bayer AG

13.8.1 Bayer AG Company Information

13.8.2 Bayer AG Bio-pharma Product Offered

13.8.3 Bayer AG Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Bayer AG Main Business Overview

13.8.5 Bayer AG Latest Developments

13.9 Eli Lilly and Company

13.9.1 Eli Lilly and Company Company Information

13.9.2 Eli Lilly and Company Bio-pharma Product Offered

13.9.3 Eli Lilly and Company Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Eli Lilly and Company Main Business Overview

13.9.5 Eli Lilly and Company Latest Developments

13.10 Novartis AG GlaxoSmithKline Plc

13.10.1 Novartis AG GlaxoSmithKline Plc Company Information

13.10.2 Novartis AG GlaxoSmithKline Plc Bio-pharma Product Offered

13.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Novartis AG GlaxoSmithKline Plc Main Business Overview

13.10.5 Novartis AG GlaxoSmithKline Plc Latest Developments

13.11 Bristol-Myers Squibb Company

13.11.1 Bristol-Myers Squibb Company Company Information

13.11.2 Bristol-Myers Squibb Company Bio-pharma Product Offered

13.11.3 Bristol-Myers Squibb Company Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Bristol-Myers Squibb Company Main Business Overview

13.11.5 Bristol-Myers Squibb Company Latest Developments

13.12 AstraZeneca PLC

13.12.1 AstraZeneca PLC Company Information

13.12.2 AstraZeneca PLC Bio-pharma Product Offered

13.12.3 AstraZeneca PLC Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 AstraZeneca PLC Main Business Overview

13.12.5 AstraZeneca PLC Latest Developments

13.13 Abbott Laboratories

13.13.1 Abbott Laboratories Company Information

13.13.2 Abbott Laboratories Bio-pharma Product Offered

13.13.3 Abbott Laboratories Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Abbott Laboratories Main Business Overview

13.13.5 Abbott Laboratories Latest Developments

14 Research Findings and Conclusion

Table 1. Bio-pharma Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Bio-pharma Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Monoclonal Antibodies

Table 4. Major Players of Recombinant Proteins

Table 5. Major Players of Granulocyte-Colony Stimulating Factor (G-CSF)

Table 6. Major Players of Interferons

Table 7. Major Players of Recombinant Human Insulin

Table 8. Major Players of Erythropoietin

Table 9. Major Players of Vaccines

Table 10. Major Players of Growth Hormones

Table 11. Major Players of Purified Proteins

Table 12. Major Players of Others

Table 13. Global Bio-pharma Sales by Type (2017-2022) & (K Pcs)

Table 14. Global Bio-pharma Sales Market Share by Type (2017-2022)

Table 15. Global Bio-pharma Revenue by Type (2017-2022) & ($ million)

Table 16. Global Bio-pharma Revenue Market Share by Type (2017-2022)

Table 17. Global Bio-pharma Sale Price by Type (2017-2022) & (USD/Pcs)

Table 18. Global Bio-pharma Sales by Application (2017-2022) & (K Pcs)

Table 19. Global Bio-pharma Sales Market Share by Application (2017-2022)

Table 20. Global Bio-pharma Revenue by Application (2017-2022)

Table 21. Global Bio-pharma Revenue Market Share by Application (2017-2022)

Table 22. Global Bio-pharma Sale Price by Application (2017-2022) & (USD/Pcs)

Table 23. Global Bio-pharma Sales by Company (2020-2022) & (K Pcs)

Table 24. Global Bio-pharma Sales Market Share by Company (2020-2022)

Table 25. Global Bio-pharma Revenue by Company (2020-2022) ($ Millions)

Table 26. Global Bio-pharma Revenue Market Share by Company (2020-2022)

Table 27. Global Bio-pharma Sale Price by Company (2020-2022) & (USD/Pcs)

Table 28. Key Manufacturers Bio-pharma Producing Area Distribution and Sales Area

Table 29. Players Bio-pharma Products Offered

Table 30. Bio-pharma Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 31. New Products and Potential Entrants

Table 32. Mergers & Acquisitions, Expansion

Table 33. Global Bio-pharma Sales by Geographic Region (2017-2022) & (K Pcs)

Table 34. Global Bio-pharma Sales Market Share Geographic Region (2017-2022)

Table 35. Global Bio-pharma Revenue by Geographic Region (2017-2022) & ($ millions)

Table 36. Global Bio-pharma Revenue Market Share by Geographic Region (2017-2022)

Table 37. Global Bio-pharma Sales by Country/Region (2017-2022) & (K Pcs)

Table 38. Global Bio-pharma Sales Market Share by Country/Region (2017-2022)

Table 39. Global Bio-pharma Revenue by Country/Region (2017-2022) & ($ millions)

Table 40. Global Bio-pharma Revenue Market Share by Country/Region (2017-2022)

Table 41. Americas Bio-pharma Sales by Country (2017-2022) & (K Pcs)

Table 42. Americas Bio-pharma Sales Market Share by Country (2017-2022)

Table 43. Americas Bio-pharma Revenue by Country (2017-2022) & ($ Millions)

Table 44. Americas Bio-pharma Revenue Market Share by Country (2017-2022)

Table 45. Americas Bio-pharma Sales by Type (2017-2022) & (K Pcs)

Table 46. Americas Bio-pharma Sales Market Share by Type (2017-2022)

Table 47. Americas Bio-pharma Sales by Application (2017-2022) & (K Pcs)

Table 48. Americas Bio-pharma Sales Market Share by Application (2017-2022)

Table 49. APAC Bio-pharma Sales by Region (2017-2022) & (K Pcs)

Table 50. APAC Bio-pharma Sales Market Share by Region (2017-2022)

Table 51. APAC Bio-pharma Revenue by Region (2017-2022) & ($ Millions)

Table 52. APAC Bio-pharma Revenue Market Share by Region (2017-2022)

Table 53. APAC Bio-pharma Sales by Type (2017-2022) & (K Pcs)

Table 54. APAC Bio-pharma Sales Market Share by Type (2017-2022)

Table 55. APAC Bio-pharma Sales by Application (2017-2022) & (K Pcs)

Table 56. APAC Bio-pharma Sales Market Share by Application (2017-2022)

Table 57. Europe Bio-pharma Sales by Country (2017-2022) & (K Pcs)

Table 58. Europe Bio-pharma Sales Market Share by Country (2017-2022)

Table 59. Europe Bio-pharma Revenue by Country (2017-2022) & ($ Millions)

Table 60. Europe Bio-pharma Revenue Market Share by Country (2017-2022)

Table 61. Europe Bio-pharma Sales by Type (2017-2022) & (K Pcs)

Table 62. Europe Bio-pharma Sales Market Share by Type (2017-2022)

Table 63. Europe Bio-pharma Sales by Application (2017-2022) & (K Pcs)

Table 64. Europe Bio-pharma Sales Market Share by Application (2017-2022)

Table 65. Middle East & Africa Bio-pharma Sales by Country (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Bio-pharma Sales Market Share by Country (2017-2022)

Table 67. Middle East & Africa Bio-pharma Revenue by Country (2017-2022) & ($ Millions)

Table 68. Middle East & Africa Bio-pharma Revenue Market Share by Country (2017-2022)

Table 69. Middle East & Africa Bio-pharma Sales by Type (2017-2022) & (K Pcs)

Table 70. Middle East & Africa Bio-pharma Sales Market Share by Type (2017-2022)

Table 71. Middle East & Africa Bio-pharma Sales by Application (2017-2022) & (K Pcs)

Table 72. Middle East & Africa Bio-pharma Sales Market Share by Application (2017-2022)

Table 73. Key Market Drivers & Growth Opportunities of Bio-pharma

Table 74. Key Market Challenges & Risks of Bio-pharma

Table 75. Key Industry Trends of Bio-pharma

Table 76. Bio-pharma Raw Material

Table 77. Key Suppliers of Raw Materials

Table 78. Bio-pharma Distributors List

Table 79. Bio-pharma Customer List

Table 80. Global Bio-pharma Sales Forecast by Region (2023-2028) & (K Pcs)

Table 81. Global Bio-pharma Sales Market Forecast by Region

Table 82. Global Bio-pharma Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Global Bio-pharma Revenue Market Share Forecast by Region (2023-2028)

Table 84. Americas Bio-pharma Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Americas Bio-pharma Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. APAC Bio-pharma Sales Forecast by Region (2023-2028) & (K Pcs)

Table 87. APAC Bio-pharma Revenue Forecast by Region (2023-2028) & ($ millions)

Table 88. Europe Bio-pharma Sales Forecast by Country (2023-2028) & (K Pcs)

Table 89. Europe Bio-pharma Revenue Forecast by Country (2023-2028) & ($ millions)

Table 90. Middle East & Africa Bio-pharma Sales Forecast by Country (2023-2028) & (K Pcs)

Table 91. Middle East & Africa Bio-pharma Revenue Forecast by Country (2023-2028) & ($ millions)

Table 92. Global Bio-pharma Sales Forecast by Type (2023-2028) & (K Pcs)

Table 93. Global Bio-pharma Sales Market Share Forecast by Type (2023-2028)

Table 94. Global Bio-pharma Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 95. Global Bio-pharma Revenue Market Share Forecast by Type (2023-2028)

Table 96. Global Bio-pharma Sales Forecast by Application (2023-2028) & (K Pcs)

Table 97. Global Bio-pharma Sales Market Share Forecast by Application (2023-2028)

Table 98. Global Bio-pharma Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 99. Global Bio-pharma Revenue Market Share Forecast by Application (2023-2028)

Table 100. Pfizer Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors

Table 101. Pfizer Bio-pharma Product Offered

Table 102. Pfizer Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Pfizer Main Business

Table 104. Pfizer Latest Developments

Table 105. F. Hoffmann-La Roche AG Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors

Table 106. F. Hoffmann-La Roche AG Bio-pharma Product Offered

Table 107. F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. F. Hoffmann-La Roche AG Main Business

Table 109. F. Hoffmann-La Roche AG Latest Developments

Table 110. Johnson & Johnson Services Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors

Table 111. Johnson & Johnson Services Bio-pharma Product Offered

Table 112. Johnson & Johnson Services Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Johnson & Johnson Services Main Business

Table 114. Johnson & Johnson Services Latest Developments

Table 115. Sanofi, Amgen Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors

Table 116. Sanofi, Amgen Bio-pharma Product Offered

Table 117. Sanofi, Amgen Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Sanofi, Amgen Main Business

Table 119. Sanofi, Amgen Latest Developments

Table 120. AbbVie Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors

Table 121. AbbVie Bio-pharma Product Offered

Table 122. AbbVie Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. AbbVie Main Business

Table 124. AbbVie Latest Developments

Table 125. Merck & Co., Inc Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors

Table 126. Merck & Co., Inc Bio-pharma Product Offered

Table 127. Merck & Co., Inc Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. Merck & Co., Inc Main Business

Table 129. Merck & Co., Inc Latest Developments

Table 130. Biogen Idec Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors

Table 131. Biogen Idec Bio-pharma Product Offered

Table 132. Biogen Idec Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 133. Biogen Idec Main Business

Table 134. Biogen Idec Latest Developments

Table 135. Bayer AG Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors

Table 136. Bayer AG Bio-pharma Product Offered

Table 137. Bayer AG Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 138. Bayer AG Main Business

Table 139. Bayer AG Latest Developments

Table 140. Eli Lilly and Company Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors

Table 141. Eli Lilly and Company Bio-pharma Product Offered

Table 142. Eli Lilly and Company Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 143. Eli Lilly and Company Main Business

Table 144. Eli Lilly and Company Latest Developments

Table 145. Novartis AG GlaxoSmithKline Plc Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors

Table 146. Novartis AG GlaxoSmithKline Plc Bio-pharma Product Offered

Table 147. Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 148. Novartis AG GlaxoSmithKline Plc Main Business

Table 149. Novartis AG GlaxoSmithKline Plc Latest Developments

Table 150. Bristol-Myers Squibb Company Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors

Table 151. Bristol-Myers Squibb Company Bio-pharma Product Offered

Table 152. Bristol-Myers Squibb Company Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 153. Bristol-Myers Squibb Company Main Business

Table 154. Bristol-Myers Squibb Company Latest Developments

Table 155. AstraZeneca PLC Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors

Table 156. AstraZeneca PLC Bio-pharma Product Offered

Table 157. AstraZeneca PLC Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 158. AstraZeneca PLC Main Business

Table 159. AstraZeneca PLC Latest Developments

Table 160. Abbott Laboratories Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors

Table 161. Abbott Laboratories Bio-pharma Product Offered

Table 162. Abbott Laboratories Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 163. Abbott Laboratories Main Business

Table 164. Abbott Laboratories Latest Developments

List of Figures

Figure 1. Picture of Bio-pharma

Figure 2. Bio-pharma Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Bio-pharma Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Bio-pharma Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Bio-pharma Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Monoclonal Antibodies

Figure 10. Product Picture of Recombinant Proteins

Figure 11. Product Picture of Granulocyte-Colony Stimulating Factor (G-CSF)

Figure 12. Product Picture of Interferons

Figure 13. Product Picture of Recombinant Human Insulin

Figure 14. Product Picture of Erythropoietin

Figure 15. Product Picture of Vaccines

Figure 16. Product Picture of Growth Hormones

Figure 17. Product Picture of Purified Proteins

Figure 18. Product Picture of Others

Figure 19. Global Bio-pharma Sales Market Share by Type in 2021

Figure 20. Global Bio-pharma Revenue Market Share by Type (2017-2022)

Figure 21. Bio-pharma Consumed in Metabolic Disorders

Figure 22. Global Bio-pharma Market: Metabolic Disorders (2017-2022) & (K Pcs)

Figure 23. Bio-pharma Consumed in Oncology

Figure 24. Global Bio-pharma Market: Oncology (2017-2022) & (K Pcs)

Figure 25. Bio-pharma Consumed in Neurological Disorders

Figure 26. Global Bio-pharma Market: Neurological Disorders (2017-2022) & (K Pcs)

Figure 27. Bio-pharma Consumed in Cardiovascular Diseases

Figure 28. Global Bio-pharma Market: Cardiovascular Diseases (2017-2022) & (K Pcs)

Figure 29. Bio-pharma Consumed in Inflammatory and Infectious Diseases

Figure 30. Global Bio-pharma Market: Inflammatory and Infectious Diseases (2017-2022) & (K Pcs)

Figure 31. Bio-pharma Consumed in Others

Figure 32. Global Bio-pharma Market: Others (2017-2022) & (K Pcs)

Figure 33. Global Bio-pharma Sales Market Share by Application (2017-2022)

Figure 34. Global Bio-pharma Revenue Market Share by Application in 2021

Figure 35. Bio-pharma Revenue Market by Company in 2021 ($ Million)

Figure 36. Global Bio-pharma Revenue Market Share by Company in 2021

Figure 37. Global Bio-pharma Sales Market Share by Geographic Region (2017-2022)

Figure 38. Global Bio-pharma Revenue Market Share by Geographic Region in 2021

Figure 39. Global Bio-pharma Sales Market Share by Region (2017-2022)

Figure 40. Global Bio-pharma Revenue Market Share by Country/Region in 2021

Figure 41. Americas Bio-pharma Sales 2017-2022 (K Pcs)

Figure 42. Americas Bio-pharma Revenue 2017-2022 ($ Millions)

Figure 43. APAC Bio-pharma Sales 2017-2022 (K Pcs)

Figure 44. APAC Bio-pharma Revenue 2017-2022 ($ Millions)

Figure 45. Europe Bio-pharma Sales 2017-2022 (K Pcs)

Figure 46. Europe Bio-pharma Revenue 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Bio-pharma Sales 2017-2022 (K Pcs)

Figure 48. Middle East & Africa Bio-pharma Revenue 2017-2022 ($ Millions)

Figure 49. Americas Bio-pharma Sales Market Share by Country in 2021

Figure 50. Americas Bio-pharma Revenue Market Share by Country in 2021

Figure 51. United States Bio-pharma Revenue Growth 2017-2022 ($ Millions)

Figure 52. Canada Bio-pharma Revenue Growth 2017-2022 ($ Millions)

Figure 53. Mexico Bio-pharma Revenue Growth 2017-2022 ($ Millions)

Figure 54. Brazil Bio-pharma Revenue Growth 2017-2022 ($ Millions)

Figure 55. APAC Bio-pharma Sales Market Share by Region in 2021

Figure 56. APAC Bio-pharma Revenue Market Share by Regions in 2021

Figure 57. China Bio-pharma Revenue Growth 2017-2022 ($ Millions)

Figure 58. Japan Bio-pharma Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Korea Bio-pharma Revenue Growth 2017-2022 ($ Millions)

Figure 60. Southeast Asia Bio-pharma Revenue Growth 2017-2022 ($ Millions)

Figure 61. India Bio-pharma Revenue Growth 2017-2022 ($ Millions)

Figure 62. Australia Bio-pharma Revenue Growth 2017-2022 ($ Millions)

Figure 63. Europe Bio-pharma Sales Market Share by Country in 2021

Figure 64. Europe Bio-pharma Revenue Market Share by Country in 2021

Figure 65. Germany Bio-pharma Revenue Growth 2017-2022 ($ Millions)

Figure 66. France Bio-pharma Revenue Growth 2017-2022 ($ Millions)

Figure 67. UK Bio-pharma Revenue Growth 2017-2022 ($ Millions)

Figure 68. Italy Bio-pharma Revenue Growth 2017-2022 ($ Millions)

Figure 69. Russia Bio-pharma Revenue Growth 2017-2022 ($ Millions)

Figure 70. Middle East & Africa Bio-pharma Sales Market Share by Country in 2021

Figure 71. Middle East & Africa Bio-pharma Revenue Market Share by Country in 2021

Figure 72. Egypt Bio-pharma Revenue Growth 2017-2022 ($ Millions)

Figure 73. South Africa Bio-pharma Revenue Growth 2017-2022 ($ Millions)

Figure 74. Israel Bio-pharma Revenue Growth 2017-2022 ($ Millions)

Figure 75. Turkey Bio-pharma Revenue Growth 2017-2022 ($ Millions)

Figure 76. GCC Country Bio-pharma Revenue Growth 2017-2022 ($ Millions)

Figure 77. Manufacturing Cost Structure Analysis of Bio-pharma in 2021

Figure 78. Manufacturing Process Analysis of Bio-pharma

Figure 79. Industry Chain Structure of Bio-pharma

Figure 80. Channels of Distribution

Figure 81. Distributors Profiles